Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Houtman

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Plos One|June 9, 2022
Identification of HCN1 as a 14-3-3 clientColten Lankford, Jon Houtman, Sheila A Baker
Cancer Medicine|August 2, 2025
Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Breast CancerNicole M G Fleege, Elise A Miller, Kelley M Kidwell, et al.
Journal for Immunotherapy of Cancer|July 31, 2021
Intratumoral talimogene laherparepvec injection with concurrent preoperative radiation in patients with locally advanced soft-tissue sarcoma of the trunk and extremities: phase IB/II trialVarun Monga, Benjamin J Miller, Munir Tanas, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Plos One|June 9, 2022
Identification of HCN1 as a 14-3-3 clientColten Lankford, Jon Houtman, Sheila A Baker
Cancer Medicine|August 2, 2025
Pilot Study of Cannabidiol for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Breast CancerNicole M G Fleege, Elise A Miller, Kelley M Kidwell, et al.
Journal for Immunotherapy of Cancer|July 31, 2021
Intratumoral talimogene laherparepvec injection with concurrent preoperative radiation in patients with locally advanced soft-tissue sarcoma of the trunk and extremities: phase IB/II trialVarun Monga, Benjamin J Miller, Munir Tanas, et al.
Pageof 1